🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

GLOBAL MARKETS-Stocks rise on recovery hopes

Published 25/01/2021, 11:13 pm
© Reuters.
EUR/USD
-
GBP/USD
-
USD/JPY
-
XAU/USD
-
US500
-
DJI
-
AXJO
-
STOXX50
-
JP225
-
HK50
-
DX
-
GC
-
LCO
-
ESZ24
-
CL
-
IXIC
-
STOXX
-
0700
-
MIAPJ0000PUS
-
CSI300
-
MIWD00000PUS
-
SX8P
-

* Graphic: Global asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates http://tmsnrt.rs/2egbfVh

By Ritvik Carvalho

LONDON, Jan 25 (Reuters) - Global shares rose to just shy of record highs, as optimism over a $1.9 trillion U.S. stimulus plan outweighed increasing COVID-19 cases and delays in vaccine supplies.

MSCI's All Country World index, which tracks stocks across 49 countries, was up 0.2% on the day. .MIWD00000PUS

E-mini futures for the S&P 500 gained 0.3%, indicating gains on Wall Street. ESc1 .N

Global equity markets have scaled record highs in recent days on bets COVID-19 vaccines will start to reduce infection rates worldwide and on a stronger U.S. economic recovery under President Joe Biden.

European stock markets opened higher, but fell back by midday in London with the pan-European STOXX 600 .STOXX flat. The continent's 50 biggest stocks fell 0.25% .STOXX50 . .EU

A rally in U.S. tech stocks to near record highs on Friday helped fuel gains in their counterparts in Asia and Europe. A European basket of tech stocks gained 1.2% .SX8P . In Asia, Chinese tech giant Tencent soared 11% 0700.HK .

Investors are also wary about towering valuations amid questions over the efficiency of the vaccines in curbing the pandemic and as U.S. lawmakers continue to debate a coronavirus aid package. eyes are on Washington D.C. as U.S. lawmakers agreed that getting the COVID-19 vaccine to Americans should be a priority even as they locked horns over the size of the U.S. pandemic relief package. markets have been eyeing a massive package, though disagreements have meant months of indecision in a country suffering more than 175,000 COVID-19 cases a day with millions out of work.

Global COVID-19 cases are inching towards 100 million with more than 2 million dead. the recent outperformance in tech stocks, investors have reiterated views that cyclical and value stocks will outperform as economies recover.

"While renewed lockdowns and mobility restrictions around the world have supported 2020 stay-home beneficiaries, we do not think the rotation into cyclicals is over," said Mark Haefele, chief investment officer at UBS Global Wealth Management.

Haefele said a broadening economic recovery, a normalization of economic activity as vaccination programmes continue, and attractive valuations for emerging-market stocks relative to developed markets were reasons for UBS shifting its preference to emerging markets.

On Friday, the Dow .DJI fell 0.57%, the S&P 500 .SPX lost 0.30% and the Nasdaq .IXIC added 0.09%. The three main U.S. indexes closed higher for the week, with the Nasdaq rising over 4%.

"Small/Mid (SMID) cap earnings were more impacted by the pandemic, and we project an earnings rebound more than 2x larger than the S&P 500," said BoFA strategists in a note.

"Historically, when Democrats control both the White House and Congress, SMID-cap returns have exceeded large cap. Also, SMID-caps are more domestically-oriented, which should benefit from on-shoring and infrastructure spending."

Sentiment in Asia was boosted by a report that China had surpassed the United States to be the largest recipient of foreign direct investment in 2020 with $163 billion in inflows. broadest index of Asia-Pacific shares outside Japan .MIAPJ0000PUS rose 1.2% to 727.24, close to last week's record high of 727.31.

The benchmark is up nearly 9% so far in January, on track for its fourth straight monthly rise.

Japan's Nikkei .N225 rebounded from falls in early trading to be up 0.7%.

Australian shares .AXJO added 0.4% after the country's drug regulator approved the Pfizer/BioNTech COVID-19 vaccine with a phased rollout likely late next month. shares rose, with the blue-chip CSI300 index .CSI300 up 1%. Hong Kong's Hang Seng index .HSI leapt 2.4% led by technology stocks.

The dollar =USD traded flat against a basket of currencies at 90.228. Major currency trading pairs were trapped in a tight range as markets awaited the Federal Reserve's Wednesday meeting.

The euro EUR= was lower 0.1% at $1.2160, while sterling GBP= was last up 0.1% at $1.3688. FRX/ The Japanese yen JPY= was last a touch lower at 103.80 per dollar.

In commodities, Brent LCOc1 gained 0.5% to $55.71 a barrel and U.S. crude CLc1 rose 0.6% to $52.67.

Gold rose 0.5% to $1,860 an ounce. XAU=

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Global markets in 2021

https://tmsnrt.rs/3ohj9g7

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.